Targeting the liver in dementia and cognitive impairment: Dietary macronutrients and diabetic therapeutics.

Journal Information

Full Title: Adv Drug Deliv Rev

Abbreviation: Adv Drug Deliv Rev

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Drug Therapy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of Competing Interest: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."

Evidence found in paper:

"The research has been funded by the National Health and Medical Research Council of Australia (1141234) and the McKnight Bequest to the Medical Foundation of the University of Sydney. N.H. is supported by the Australian Diabetes Society Skip Martin ECR Fellowship and The University of Sydney SOAR Prize. D.W. is supported by The National Institutes of Health, National Institute on Aging (F32AG069361). L.W is supported by the ANZAC Research Institute Nano DeLiver Postgraduate Scholarship."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025